Welcure Drugs & Pharmaceuticals share news and announcements

BSE: 524661Pharmaceuticals & BiotechnologySmall Cap

₹0.18₹0.02 (10.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹0.20.

52-week range of traded prices to 23 Oct 2026

₹0.17Low, 23 Oct 2026₹0.72High, 23 Oct 2025

Market cap: ₹22 Cr3,646th largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 76,25,873

Welcure Drugs & Pharmaceuticals share news and announcements

550 announcements, routine notices left out, newest first. Page 6 of 11.

Sep 2022
- 8 Sep · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandeep Jain (opens in a new tab)
- 7 Sep · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Mr. Sandeep Jain, Immediate Relative had send Form C under the above .... (opens in a new tab)
- 7 Sep · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Mr. Dharam Chand Jain, Promoter of the Company had send Form C under .... (opens in a new tab)
- 7 Sep · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandeep Jain (opens in a new tab)
- 7 Sep · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dharam Chand Jain (opens in a new tab)
- 1 Sep · Management
  (the 'Listing Regulations'), we wish to inform .... (opens in a new tab)
- 1 Sep · Management
  (the 'Listing Regulations'), we wish to inform .... (opens in a new tab)
Aug 2022
- 26 Aug · Management
  We wish to inform you that Mr. Mohd Shahbaz Alam (DIN: 06824697) and Mr. Gagan Juneja .... (opens in a new tab)
- 26 Aug · Management
  We wish to inform you that Mr. Gagan Juneja, has resigned from the position of Chief .... (opens in a new tab)
Jul 2022
- 28 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pawan Kumar Khurana (opens in a new tab)
- 28 Jul · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Mr. Dharam Chand Jain, Promoter of the Company had send Form C under .... (opens in a new tab)
- 28 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dharam Chand Jain (opens in a new tab)
- 27 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dharam Chand Jain (opens in a new tab)
- 26 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dharam Chand Jain (opens in a new tab)
- 22 Jul · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Mr. Sandeep Jain, Immediate Relative had send Form C under the above .... (opens in a new tab)
- 22 Jul · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Mr. Sanjeev Jain, Immediate Relative along with other Immediate Relative/ .... (opens in a new tab)
- 21 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandeep Jain & Others (opens in a new tab)
- 16 Jul · Results
  Pursuant to the provisions of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... (opens in a new tab)
- 16 Jul · Board meeting
  30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), .... (opens in a new tab)
- 14 Jul · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
  6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Mr. Sandeep Jain, Immediate Relative had send Form C under the above .... (opens in a new tab)
- 11 Jul · Board meeting
  Meeting on 16 Jul 2022: quarterly results
- 9 Jul · Board meeting
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/07/2022 ,inter alia, to consider and approve the Un-Audited .... (opens in a new tab)
- 6 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
- 29 Jun · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/524661 ....
- 28 Jun · Meeting
  In continuation of our letter dated 27th June, 2022 regarding proceeding of 30th Annual General Meeting ('AGM') of Welcure Drugs & Pharmaceuticals Ltd ('the Company') held on Monday, 27th .... (opens in a new tab)
- 27 Jun · Meeting
  The 30th Annual General Meeting ('AGM') of Welcure Drugs and Pharmaceuticals Limited (the 'Company') was held today i.e. Monday, 27th June, 2022 at 10:00 A.M. through Video Conferencing .... (opens in a new tab)
May 2022
- 26 May · Corporate action
  Pursuant to Regulation 91 of the Companies Act, 2013 and Regulation 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015; Register of Members and Share Transfer .... (opens in a new tab)
- 26 May · Reg. 34 (1) Annual Report.
  Annual Report for financial year ended March 31, .... (opens in a new tab)
- 26 May · Meeting
  Pursuant to provisions of Regulation 30, 34 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,circular dated 5th May, .... (opens in a new tab)
- 2 May · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
  Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars .... (opens in a new tab)
Apr 2022
- 15 Apr · Board meeting
  Pursuant to the provisions of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... (opens in a new tab)
- 15 Apr · Outcome Of Board Of Directors Meeting- 15Th April, 2022
  30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that .... (opens in a new tab)
- 11 Apr · Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Year Ended March 31, 2022
  Certificate obtained from M/s A.K. Nandwani & .... (opens in a new tab)
- 8 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2022
  We herewith attach the certificate for the year ended March 31, 2022, duly signed .... (opens in a new tab)
- 8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 7 Apr · Board meeting
  Meeting on 15 Apr 2022: audited results
- 7 Apr · Board meeting
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2022 ,inter alia, to consider and approve the Audited .... (opens in a new tab)
Jan 2022
- 22 Jan · Results
  Pursuant to the provisions of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... (opens in a new tab)
- 22 Jan · Results
  30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), .... (opens in a new tab)
- 13 Jan · Board meeting
  Meeting on 22 Jan 2022: quarterly results
- 13 Jan · Board meeting
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2022 ,inter alia, to consider and approve the Un-Audited .... (opens in a new tab)
- 12 Jan · Shareholding for the Period Ended December 31, 2021
  Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
- 12 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Oct 2021
- 27 Oct · Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Disclosure of Related Party Transactions on a .... (opens in a new tab)
- 25 Oct · Results
  Pursuant to the provisions of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... (opens in a new tab)
- 25 Oct · Results
  30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), .... (opens in a new tab)
- 18 Oct · Board meeting
  Meeting on 25 Oct 2021: quarterly results
- 16 Oct · Board meeting
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2021 ,inter alia, to consider and approve the Un-Audited .... (opens in a new tab)
- 13 Oct · Shareholding for the Period Ended September 30, 2021
  Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....
- 11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0

Welcure Drugs & Pharmaceuticals share news and announcements

Sep 2022

Aug 2022

Jul 2022

Jun 2022

May 2022

Apr 2022

Jan 2022

Oct 2021